Home › Funds › Catalio Capital Management, LP › PBLS
Catalio Capital Management, LP position in PBLS
PARABILIS MEDICINES INC · Health Care
Catalio Capital Management, LP reported holding 824,043 shares of PBLS (PARABILIS MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$22.6M, representing 4.24% of its reported portfolio and ranking #8 among its reported holdings. Catalio Capital Management, LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's PBLS position evolved
Catalio Capital Management, LP first disclosed a stake in PBLS in Q2 2026 at 824,043 shares (US$22.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 824.04K | $22.55M | New |
About PBLS and 13F data
PBLS (PARABILIS MEDICINES INC) is a Health Care company. 89 other funds we track also report a position in PBLS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$791.9M), ARCH Venture Management, LLC (US$175.5M), venBio Partners LLC (US$144.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PBLS
- RA CAPITAL MANAGEMENT, L.P. 28.93M sh · $791.91M · Q2 2026
- ARCH Venture Management, LLC 6.41M sh · $175.52M · Q2 2026
- venBio Partners LLC 5.27M sh · $144.15M · Q2 2026
- Alphabet Inc. 4.92M sh · $134.65M · Q2 2026
- Nextech Invest Ltd. 4.66M sh · $127.63M · Q2 2026
- Cormorant Asset Management, LP 4.62M sh · $126.33M · Q2 2026
- REGENERON PHARMACEUTICALS, INC. 4.17M sh · $114.04M · Q2 2026
- Siren, L.L.C. 2.99M sh · $81.90M · Q2 2026
- Farallon Capital Management 2.37M sh · $64.82M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.37M sh · $64.82M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.92M sh · $52.57M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.88M sh · $51.47M · Q2 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held PBLS?
Catalio Capital Management, LP has disclosed PBLS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Catalio Capital Management, LP's current position in PBLS?
As of Q2 2026, Catalio Capital Management, LP holds 824.04K shares of PBLS (PARABILIS MEDICINES INC), valued at $22.55M, representing 4.24% of its reported portfolio and ranking #8.
Has Catalio Capital Management, LP been buying or selling PBLS?
In the latest 13F filing (Q2 2026), Catalio Capital Management, LP newly opened its position in PBLS.
Which other funds hold PBLS?
Other major institutional holders of PBLS include RA CAPITAL MANAGEMENT, L.P., ARCH Venture Management, LLC, venBio Partners LLC, among 89 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.